|
covid-19 |
53 |
|
sars-cov-2 |
46 |
|
mucosal immunity |
17 |
|
neutralizing antibody |
16 |
|
receptor binding domain |
16 |
|
live attenuated vaccine |
15 |
|
ace2 |
14 |
|
human immunodeficiency virus |
14 |
|
transmission |
14 |
|
vaccine |
14 |
|
inactivated vaccine |
13 |
|
rnai |
13 |
|
sace2 |
13 |
|
animal |
12 |
|
coronavirus |
12 |
|
hiv-1 |
12 |
|
spike protein |
12 |
|
2′-o-methyltransferase |
11 |
|
adult |
11 |
|
anthranilic acid |
11 |
|
antiviral agents - chemical synthesis - chemistry - pharmacology |
11 |
|
broad spectrum |
11 |
|
carboxypeptidases - antagonists & inhibitors - metabolism |
11 |
|
endoplasmic reticulum |
11 |
|
influenza a virus |
11 |
|
neutralizing antibodies |
11 |
|
nsp16 |
11 |
|
sars virus - drug effects - growth & development - metabolism - physiology |
11 |
|
severe acute respiratory syndrome - drug therapy |
11 |
|
sterilizing immunity |
11 |
|
t-cell response |
11 |
|
viral matrix proteins - antagonists & inhibitors - metabolism |
11 |
|
disease severity |
10 |
|
human neutralizing antibody |
10 |
|
immunity |
10 |
|
linker-immunodominant site |
10 |
|
lung injury |
10 |
|
male |
10 |
|
nasal turbinate |
10 |
|
phage display |
10 |
|
upper respiratory tract |
10 |
|
ba.5.2 |
9 |
|
coronavac |
9 |
|
fc-rbd |
9 |
|
genotype |
9 |
|
immune protection |
9 |
|
omicron variant |
9 |
|
sars-cov-2 variants of concern |
9 |
|
xbb.1 |
9 |
|
age |
8 |
|
aged |
8 |
|
aids |
8 |
|
animals |
8 |
|
antibody blood level |
8 |
|
antibody titer |
8 |
|
b-cell suppression |
8 |
|
delns1-ncov-rbd laiv |
8 |
|
intranasal |
8 |
|
mice |
8 |
|
mice, inbred balb c |
8 |
|
mitochondrial dysfunction |
8 |
|
phase-1 |
8 |
|
spike mutant |
8 |
|
spike s1/s2 mutant |
8 |
|
t cell exhaustion |
8 |
|
acute infection |
7 |
|
administration, oral |
7 |
|
antibodies, viral - blood - immunology |
7 |
|
antibody |
7 |
|
convalescent |
7 |
|
covid19 |
7 |
|
dendritic cell |
7 |
|
furin cleavage prra motif |
7 |
|
icu patient |
7 |
|
immunization, secondary |
7 |
|
injections, intramuscular |
7 |
|
neutralization tests |
7 |
|
reinfection |
7 |
|
sars virus - immunology |
7 |
|
vaccines, dna - administration & dosage - immunology |
7 |
|
viral variants |
7 |
|
astrovirus |
6 |
|
bacterial vaccines - administration & dosage - immunology |
6 |
|
escherichia coli proteins |
6 |
|
humans |
6 |
|
immunization schedule |
6 |
|
immunoglobulin g - blood |
6 |
|
injections, intraperitoneal |
6 |
|
interferon-gamma - analysis |
6 |
|
interleukin-4 - analysis |
6 |
|
live-attenuated influenza-based vaccine |
6 |
|
membrane glycoproteins - administration & dosage - genetics - immunology |
6 |
|
memory t cell |
6 |
|
mitochondrial dysfunction (md) |
6 |
|
models, animal |
6 |
|
nasal prevention |
6 |
|
pd1-based dna vaccine |
6 |
|
phylogenetic tree |
6 |
|
rodents |
6 |
|
severe acute respiratory syndrome - prevention & control |
6 |
|
t-cell functionality |
6 |
|
vaccines, synthetic - administration & dosage - immunology |
6 |
|
viral envelope proteins - administration & dosage - genetics - immunology |
6 |
|
virus discovery |
6 |
|
whole genome |
6 |
|
ace2 expression and distribution |
5 |
|
adenosinergic signaling pathway |
5 |
|
cd4 t cell |
5 |
|
children |
5 |
|
china |
5 |
|
cytokines |
5 |
|
entpd1/cd39 |
5 |
|
et5e/cd73 |
5 |
|
extracellular adenosine |
5 |
|
glycosylation |
5 |
|
highly active antiretroviral therapy |
5 |
|
immune response |
5 |
|
immunoglobulins |
5 |
|
immunotherapy |
5 |
|
infectious disease |
5 |
|
lung development |
5 |
|
lung progenitor cells |
5 |
|
macrophages |
5 |
|
mdscs |
5 |
|
molecular epidemiology |
5 |
|
monoclonal antibody |
5 |
|
mutation |
5 |
|
nicotinamide mononucleotide |
5 |
|
patients’ ages |
5 |
|
pd1 |
5 |
|
pulmonology |
5 |
|
sars-cov-2 virus |
5 |
|
t cell activation |
5 |
|
vulnerability |
5 |
|
animal model |
4 |
|
antigen spreading |
4 |
|
cd8+t cells |
4 |
|
cd8-positive t-lymphocytes - immunology - virology |
4 |
|
cellular immune response |
4 |
|
chimpanzee adenovirus vector |
4 |
|
china - epidemiology |
4 |
|
crf01-ae |
4 |
|
ctls |
4 |
|
dna vaccine |
4 |
|
drug resistance, viral - genetics |
4 |
|
drug susceptibility |
4 |
|
entry inhibitor |
4 |
|
epidemics |
4 |
|
female |
4 |
|
general population |
4 |
|
genes, gag |
4 |
|
genes, pol |
4 |
|
glycomics |
4 |
|
glycoprotein |
4 |
|
hiv |
4 |
|
hiv core protein p24 - immunology |
4 |
|
hiv infections - complications - epidemiology - virology |
4 |
|
hiv infections - prevention and control |
4 |
|
hiv-1 - classification - drug effects - genetics |
4 |
|
hiv-1 - classification - genetics - physiology |
4 |
|
hiv-1 - immunology |
4 |
|
hiv-1 - pathogenicity |
4 |
|
human programmed cell death protein 1 |
4 |
|
humoral immune response |
4 |
|
immunology and microbiology section |
4 |
|
influenza vaccines |
4 |
|
interferon-gamma - metabolism |
4 |
|
mass spectrometry |
4 |
|
memory cd8 t cell response |
4 |
|
mesothelioma |
4 |
|
middle aged |
4 |
|
modelling |
4 |
|
modified vaccinia tiantan |
4 |
|
monocytes - virology |
4 |
|
mrna vaccine |
4 |
|
ns1 |
4 |
|
pd-1 |
4 |
|
persistent virus infection |
4 |
|
phylogeny |
4 |
|
pregnancy |
4 |
|
pregnancy complications, infectious - epidemiology |
4 |
|
prevalence |
4 |
|
programmed cell death 1 receptor - immunology |
4 |
|
protective immunity |
4 |
|
recombination, genetic |
4 |
|
replication capacity |
4 |
|
sanguisorba officinalis |
4 |
|
sars-cov-2 vaccine |
4 |
|
sexual transmission |
4 |
|
single-dose immunization |
4 |
|
suppressor of cytokine signaling proteins - genetics |
4 |
|
traditional chinese medicine |
4 |
|
transcriptional activation |
4 |
|
vaccination |
4 |
|
virotherapy |
4 |
|
young adult |
4 |
|
adeno-associated virus |
3 |
|
allergology and immunology |
3 |
|
amino acid motifs |
3 |
|
amino terminal sequence |
3 |
|
animal experiment |
3 |
|
animal tissue |
3 |
|
anti-hiv agents - chemical synthesis - pharmacology |
3 |
|
antibodies, neutralizing - genetics - immunology |
3 |
|
bcg |
3 |
|
beropt |
3 |
|
binding sites |
3 |
|
blood donors |
3 |
|
cells, cultured |
3 |
|
clinical article |
3 |
|
combination antiretroviral therapy |
3 |
|
ctla-4 |
3 |
|
cytotoxic t lymphocytes |
3 |
|
d42pd1 |
3 |
|
dna, recombinant - genetics |
3 |
|
drug resistance, viral - drug effects |
3 |
|
drug synergism |
3 |
|
epithelial cells - virology |
3 |
|
escc |
3 |
|
genetic variation |
3 |
|
hepacivirus - classification - genetics |
3 |
|
hepatitis c - epidemiology - virology |
3 |
|
hiv infections - drug therapy - virology |
3 |
|
hiv infections - epidemiology - transmission |
3 |
|
hiv infections - epidemiology - virology |
3 |
|
hiv reverse transcriptase - antagonists and inhibitors - genetics - metabolism |
3 |
|
hiv-1 - classification - genetics |
3 |
|
hiv-1 - drug effects |
3 |
|
hiv-1 - drug effects - enzymology - genetics |
3 |
|
humanized mouse |
3 |
|
immune checkpoint blockade |
3 |
|
immunity, mucosal - immunology |
3 |
|
immunohistochemistry |
3 |
|
integrin 4β7 |
3 |
|
leukocytes, mononuclear - drug effects - virology |
3 |
|
medical sciences |
3 |
|
microbial sensitivity tests |
3 |
|
models, molecular |
3 |
|
mycobacterium tuberculosis |
3 |
|
neutralization |
3 |
|
nevirapine - pharmacology |
3 |
|
pd1-based vaccination |
3 |
|
pyranocoumarins - chemical synthesis - pharmacology |
3 |
|
reverse transcriptase inhibitors - chemical synthesis - pharmacology |
3 |
|
rm-act-1 |
3 |
|
salivary ducts - virology |
3 |
|
sars |
3 |
|
sars virus - isolation and purification - pathogenicity |
3 |
|
sars-cov |
3 |
|
severe acute respiratory syndrome - veterinary - virology |
3 |
|
shiv |
3 |
|
smallpox vaccine - administration and dosage - immunology |
3 |
|
soluble pd1-based vaccination |
3 |
|
t cell immunity |
3 |
|
tuberculosis |
3 |
|
tumor |
3 |
|
twist1 antigen |
3 |
|
vaccinia |
3 |
|
vaccinia - immunology - prevention and control |
3 |
|
vaccinia virus - genetics |
3 |
|
vaccinia virus - genetics - immunology |
3 |
|
vedolizumab |
3 |
|
virus replication - drug effects |
3 |
|
35b5 |
2 |
|
adcc |
2 |
|
administration, intranasal |
2 |
|
aids (艾滋病) |
2 |
|
amino acid substitution - genetics |
2 |
|
anti-hiv agents - chemical synthesis - chemistry - pharmacology |
2 |
|
antibodies, monoclonal - immunology - isolation and purification - therapeutic use |
2 |
|
antibodies, neutralizing - immunology |
2 |
|
antibodies, viral - biosynthesis |
2 |
|
antibodies, viral - chemistry |
2 |
|
antibodies, viral - immunology - isolation and purification - therapeutic use |
2 |
|
antibody somatic maturation |
2 |
|
antigenic shift |
2 |
|
apoptosis |
2 |
|
bacillus calmette-guérin |
2 |
|
cannabinoids |
2 |
|
ccr7 |
2 |
|
cd4 t cells |
2 |
|
cd4-induced |
2 |
|
cdna |
2 |
|
cell biology |
2 |
|
cell culture |
2 |
|
cell isolation |
2 |
|
cell line |
2 |
|
central memory cd4 t cells |
2 |
|
chimeric |
2 |
|
chinese macaques |
2 |
|
chinese rhesus monkey |
2 |
|
chromones - chemical synthesis - chemistry - pharmacology |
2 |
|
combinatorial chemistry techniques |
2 |
|
communicable diseases medical sciences |
2 |
|
coumarins - chemical synthesis - chemistry - pharmacology |
2 |
|
crf01_ae |
2 |
|
crf07_bc |
2 |
|
cross-protection |
2 |
|
disease models, animal |
2 |
|
disease progression |
2 |
|
dissociation |
2 |
|
dna methylation |
2 |
|
dna, viral - genetics |
2 |
|
drug resistance |
2 |
|
effector/effector memory cd4 t cells |
2 |
|
epitope |
2 |
|
fujian |
2 |
|
gene deletion |
2 |
|
gene expression |
2 |
|
genes, viral |
2 |
|
genetic vectors |
2 |
|
genome |
2 |
|
genomic dna |
2 |
|
germline antibodies |
2 |
|
glycan |
2 |
|
green fluorescent proteins - genetics |
2 |
|
gut-homing t cell |
2 |
|
haart |
2 |
|
hand |
2 |
|
hela cells |
2 |
|
hemagglutinin |
2 |
|
highly pathogenic avian influenza virus |
2 |
|
hiv infection |
2 |
|
hiv infections - drug therapy - genetics |
2 |
|
hiv-1 - drug effects - genetics |
2 |
|
hiv-1 - genetics |
2 |
|
hiv-1 latent infection |
2 |
|
human monoclonal antibody |
2 |
|
ige+b cell |
2 |
|
immunology |
2 |
|
in vivo protection |
2 |
|
influenza vaccine |
2 |
|
influenza viruses |
2 |
|
lung pathogenesis |
2 |
|
macaca mulatta - virology |
2 |
|
membrane glycoproteins - antagonists and inhibitors - chemistry - immunology |
2 |
|
membrane glycoproteins - chemistry - genetics - immunology |
2 |
|
membrane glycoproteins - immunology |
2 |
|
microscopy |
2 |
|
monoclonal antibodies |
2 |
|
msm |
2 |
|
mucosal vaccine |
2 |
|
mutagenesis |
2 |
|
mvtt |
2 |
|
mvtt zci |
2 |
|
newly emerging h5 viruses |
2 |
|
nsg |
2 |
|
nucleocapsid proteins - immunology |
2 |
|
omicron |
2 |
|
peptidyl-dipeptidase a - chemistry - genetics - metabolism |
2 |
|
pyranocoumarins - chemical synthesis - chemistry - pharmacology |
2 |
|
rabbits |
2 |
|
rbd |
2 |
|
receptor-binding domain |
2 |
|
receptors, ccr5 - physiology |
2 |
|
receptors, virus - physiology |
2 |
|
recombinant fusion proteins |
2 |
|
rhesus macaque |
2 |
|
sars virus - genetics - immunology |
2 |
|
sars virus - immunology - physiology |
2 |
|
sars virus - physiology |
2 |
|
severe acute respiratory syndrome - enzymology - pathology - virology |
2 |
|
severe acute respiratory syndrome - immunology - physiopathology |
2 |
|
simian acquired immunodeficiency syndrome - virology |
2 |
|
siv |
2 |
|
smallpox |
2 |
|
smallpox - immunology - prevention and control |
2 |
|
smallpox vaccine - administration and dosage - biosynthesis - genetics - immunology |
2 |
|
stereoisomerism |
2 |
|
structure-activity relationship |
2 |
|
subtype b' |
2 |
|
t-cell differentiation |
2 |
|
terminal repeat sequences - genetics |
2 |
|
th1 |
2 |
|
th17 |
2 |
|
thc |
2 |
|
tiantan |
2 |
|
tissue-resident memory t cell |
2 |
|
transmitted/founder |
2 |
|
treg |
2 |
|
v2 |
2 |
|
vaccine (疫苗) |
2 |
|
vaccinia (痘苗) |
2 |
|
vaccinia tian tan |
2 |
|
vaccinia tiantan (天坛痘苗) |
2 |
|
vaccinia virus - genetics - immunology - pathogenicity |
2 |
|
vaccinia virus - genetics - immunology - pathogenicity - physiology |
2 |
|
viral envelope proteins - antagonists and inhibitors - chemistry - immunology |
2 |
|
viral envelope proteins - chemistry - genetics - immunology |
2 |
|
viral envelope proteins - immunology |
2 |
|
viral vaccines - genetics - immunology - metabolism |
2 |
|
viral vector |
2 |
|
viral vector (病毒载体) |
2 |
|
virus internalization |
2 |
|
virus replication |
2 |
|
virus replication - drug effects - genetics |
2 |
|
virus replication - genetics |
2 |
|
acquired immunodeficiency syndrome - drug therapy |
1 |
|
acquired immunodeficiency syndrome - epidemiology - genetics |
1 |
|
acquired immunodeficiency syndrome - virology |
1 |
|
acute disease |
1 |
|
ad5 |
1 |
|
adaptation, physiological |
1 |
|
adenoviruses, human - genetics - immunology |
1 |
|
adjuvant |
1 |
|
adjuvants, immunologic - administration & dosage |
1 |
|
admva |
1 |
|
adolescent |
1 |
|
advax |
1 |
|
africa, western |
1 |
|
aids vaccines - administration & dosage - genetics - immunology |
1 |
|
aids vaccines - administration and dosage - adverse effects - immunology |
1 |
|
aids vaccines - immunology |
1 |
|
amino acid sequence |
1 |
|
amino acid substitution |
1 |
|
animals, domestic - virology |
1 |
|
antagonists |
1 |
|
anti-hiv |
1 |
|
anti-hiv agents - administration & dosage - chemical synthesis - pharmacokinetics |
1 |
|
anti-hiv agents - chemistry - pharmacology - therapeutic use |
1 |
|
antibodies, viral - blood |
1 |
|
antibody specificity |
1 |
|
antigen binding |
1 |
|
antigens, cd - immunology |
1 |
|
antigens, cd - physiology |
1 |
|
antigens, cd1 - genetics |
1 |
|
antigens, cd1d |
1 |
|
antigens, cd4 - physiology |
1 |
|
antigens, differentiation - immunology |
1 |
|
antigens, viral - chemistry - genetics |
1 |
|
antiretroviral |
1 |
|
antiretroviral drug |
1 |
|
antiretroviral therapy |
1 |
|
antiviral activity |
1 |
|
base sequence |
1 |
|
bi-bnab |
1 |
|
biia-sg |
1 |
|
binding affinity |
1 |
|
binding site |
1 |
|
biological availability |
1 |
|
biological characterization |
1 |
|
blood transfusion - adverse effects |
1 |
|
blotting, western |
1 |
|
brain - virology |
1 |
|
calanolide a |
1 |
|
cancer immunobiology |
1 |
|
cancer-associated fibroblast |
1 |
|
ccr2b |
1 |
|
ccr5 |
1 |
|
ccr5 receptor |
1 |
|
cd34 + progenitor cells |
1 |
|
cd4 lymphocyte count |
1 |
|
cd4+ lymphocytopenia |
1 |
|
cd4+ tcm cells |
1 |
|
cd4-positive t-lymphocytes |
1 |
|
cd4-positive t-lymphocytes - cytology - immunology |
1 |
|
cd4-positive t-lymphocytes - immunology |
1 |
|
cd4-positive t-lymphocytes - immunology - virology |
1 |
|
cd8-positive t-lymphocytes - cytology - immunology |
1 |
|
cd8-positive t-lymphocytes - immunology |
1 |
|
cdna synthesis |
1 |
|
cdna合成 |
1 |
|
cell activation |
1 |
|
cell adhesion molecules |
1 |
|
cell adhesion molecules - metabolism |
1 |
|
cell dysfunction |
1 |
|
cell line, transformed |
1 |
|
cellular immunity |
1 |
|
cellular immunology |
1 |
|
cercocebus |
1 |
|
cercocebus - virology |
1 |
|
cercocebus atys - virology |
1 |
|
cervix uteri - immunology - virology |
1 |
|
chemical resolution |
1 |
|
chemokines - immunology |
1 |
|
child |
1 |
|
child, preschool |
1 |
|
cloning, molecular |
1 |
|
cluster analysis |
1 |
|
coculture techniques |
1 |
|
cohort studies |
1 |
|
conditional gene expression |
1 |
|
conditional splicing |
1 |
|
conserved sequence |
1 |
|
cordatolide a |
1 |
|
coreceptor |
1 |
|
coreceptor switch |
1 |
|
cos cells |
1 |
|
crf (circulating recombination forms) |
1 |
|
cross reactions |
1 |
|
cross reactions - genetics - immunology |
1 |
|
cxcr4 |
1 |
|
cytokines - biosynthesis |
1 |
|
cytopathogenic effect, viral |
1 |
|
cytotoxic t lymphocyte |
1 |
|
dendritic cells - immunology |
1 |
|
dendritic cells - metabolism - virology |
1 |
|
disease outbreaks |
1 |
|
dna |
1 |
|
dna demethylating agents |
1 |
|
dna primers - genetics |
1 |
|
dna, viral - chemistry - genetics |
1 |
|
dogs |
1 |
|
dose-response relationship, immunologic |
1 |
|
dose-sparing |
1 |
|
double-blind method |
1 |
|
dual promoter dna vaccine |
1 |
|
emigration and immigration |
1 |
|
enantioselectivity |
1 |
|
endothelium, vascular - metabolism - virology |
1 |
|
enzyme-linked immunosorbent assay |
1 |
|
epithelial cells - ultrastructure - virology |
1 |
|
ethnic groups - statistics & numerical data |
1 |
|
evolution, molecular |
1 |
|
fibroblasts - ultrastructure - virology |
1 |
|
fibrosis |
1 |
|
fms-related tyrosine kinase 3 ligand |
1 |
|
gabon |
1 |
|
gag gene products, human immunodeficiency virus - immunology |
1 |
|
galactosylceramides - administration & dosage |
1 |
|
gene products, env - analysis |
1 |
|
gene products, env - genetics - immunology - metabolism |
1 |
|
gene products, env - genetics - metabolism |
1 |
|
gene products, env - genetics - physiology |
1 |
|
gene products, env - metabolism |
1 |
|
gene products, gag - analysis |
1 |
|
gene products, gag - chemistry - genetics |
1 |
|
gene products, gag - genetics - immunology - metabolism |
1 |
|
gene products, nef - genetics - immunology - metabolism |
1 |
|
gene products, pol - genetics - immunology - metabolism |
1 |
|
gene products, tat - genetics - immunology - metabolism |
1 |
|
genes - genetics |
1 |
|
genes, env |
1 |
|
genes, gag - genetics |
1 |
|
genes, vpu |
1 |
|
genetic predisposition to disease |
1 |
|
genome, viral |
1 |
|
global health |
1 |
|
healthy individuals |
1 |
|
henan |
1 |
|
hepacivirus - genetics - metabolism - pathogenicity |
1 |
|
hepatocellular carcinoma |
1 |
|
heterocycles |
1 |
|
heterologous vaccine |
1 |
|
heterozygote detection |
1 |
|
histone deacetylase inhibitors |
1 |
|
hiv - genetics - metabolism |
1 |
|
hiv antibodies - biosynthesis |
1 |
|
hiv antibodies - blood |
1 |
|
hiv envelope protein gp120 - immunology |
1 |
|
hiv envelope protein gp160 - genetics |
1 |
|
hiv fusion inhibitors - chemistry - pharmacology - therapeutic use |
1 |
|
hiv infections - drug therapy |
1 |
|
hiv infections - epidemiology - prevention & control - transmission |
1 |
|
hiv infections - epidemiology - prevention & control - transmission - virology |
1 |
|
hiv infections - epidemiology - transmission - virology |
1 |
|
hiv infections - genetics - virology |
1 |
|
hiv infections - immunology - physiopathology - transmission - virology |
1 |
|
hiv infections - immunology - transmission - virology |
1 |
|
hiv infections - metabolism |
1 |
|
hiv infections - prevention & control |
1 |
|
hiv infections - virology |
1 |
|
hiv integrase inhibitors - chemistry - pharmacology - therapeutic use |
1 |
|
hiv long-term survivors |
1 |
|
hiv protease inhibitors - chemistry - pharmacology - therapeutic use |
1 |
|
hiv seroprevalence |
1 |
|
hiv-1 - classification - genetics - isolation & purification |
1 |
|
hiv-1 - classification - metabolism - pathogenicity |
1 |
|
hiv-1 - genetics - immunology |
1 |
|
hiv-1 - genetics - isolation & purification |
1 |
|
hiv-1 - genetics - metabolism - pathogenicity |
1 |
|
hiv-1 - isolation & purification - pathogenicity - physiology |
1 |
|
hiv-1 - physiology |
1 |
|
hiv-1 infections |
1 |
|
hiv-1 subtype |
1 |
|
hiv-1/aids |
1 |
|
hiv-2 - classification - genetics - immunology |
1 |
|
hiv-2 - classification - immunology |
1 |
|
hiv-2 - immunology |
1 |
|
hiv-2 - physiology |
1 |
|
homozygote |
1 |
|
hubei |
1 |
|
immigrants |
1 |
|
immune breadth |
1 |
|
immune potency |
1 |
|
immunity, cellular - drug effects |
1 |
|
immunization |
1 |
|
immunization - methods |
1 |
|
immunization, secondary - methods |
1 |
|
infected patients |
1 |
|
infection |
1 |
|
infectious disease transmission, vertical |
1 |
|
injections, intravenous |
1 |
|
integrins |
1 |
|
interferon-gamma - immunology |
1 |
|
interferon-gamma - secretion |
1 |
|
interferon-γ |
1 |
|
intestines - immunology |
1 |
|
jak/stat |
1 |
|
kinetics |
1 |
|
lectins - metabolism |
1 |
|
lectins, c-type - metabolism |
1 |
|
leukocytes, mononuclear - immunology |
1 |
|
leukocytes, mononuclear - virology |
1 |
|
liver immunology |
1 |
|
long-term therapeutic efficacy |
1 |
|
loxp-splice-loxp |
1 |
|
lymph nodes - cytology - immunology |
1 |
|
lymphopenia - immunology - virology |
1 |
|
macaca |
1 |
|
macaca mulatta |
1 |
|
macaca mulatta (恒河猴) |
1 |
|
macaca nemestrina |
1 |
|
macaque |
1 |
|
macaques |
1 |
|
major antigenic determinant |
1 |
|
malaria - immunology - prevention and control |
1 |
|
malaria vaccines - immunology |
1 |
|
mangabey |
1 |
|
maturation |
1 |
|
membrane fusion |
1 |
|
membrane glycoproteins - chemistry - genetics - immunology - physiology |
1 |
|
membrane glycoproteins - genetics |
1 |
|
membrane glycoproteins - genetics - immunology - metabolism |
1 |
|
membrane glycoproteins - genetics - metabolism |
1 |
|
membrane glycoproteins - metabolism |
1 |
|
mice, inbred strains |
1 |
|
mice, knockout |
1 |
|
microscopy, electron |
1 |
|
models, chemical |
1 |
|
molecular cloning |
1 |
|
molecular sequence data |
1 |
|
molecular structure |
1 |
|
monocyte |
1 |
|
mosaic gag antigen |
1 |
|
mucosal vaccination |
1 |
|
mucous membrane - immunology |
1 |
|
multiple-site vaccination |
1 |
|
mutagenesis, site-directed |
1 |
|
mutation - genetics |
1 |
|
mva |
1 |
|
myeloid-derived immune suppressive cells |
1 |
|
new york city |
1 |
|
nkt cells |
1 |
|
nyc |
1 |
|
organ specificity |
1 |
|
overlapping genes |
1 |
|
paid blood donor |
1 |
|
passage |
1 |
|
pathogenesis |
1 |
|
peptidyl-dipeptidase a - genetics - metabolism |
1 |
|
phenotype |
1 |
|
photobiotin probe |
1 |
|
plasmids - genetics |
1 |
|
plasmodium berghei - genetics - immunology |
1 |
|
polymerase chain reaction |
1 |
|
polymorphism, genetic |
1 |
|
polysaccharides - immunology |
1 |
|
primary hiv-1 infection |
1 |
|
promoter regions, genetic - genetics |
1 |
|
prostitution - statistics & numerical data |
1 |
|
protein binding |
1 |
|
protein structure, tertiary |
1 |
|
pyrrolidines - administration & dosage - chemical synthesis - pharmacokinetics |
1 |
|
raccoon dogs |
1 |
|
rapid progression |
1 |
|
rats |
1 |
|
reassortant viruses - genetics |
1 |
|
receptors, ccr1 |
1 |
|
receptors, ccr2 |
1 |
|
receptors, ccr3 |
1 |
|
receptors, ccr5 |
1 |
|
receptors, ccr5 - antagonists & inhibitors |
1 |
|
receptors, ccr5 - deficiency - genetics - physiology |
1 |
|
receptors, ccr5 - genetics - immunology |
1 |
|
receptors, ccr5 - genetics - physiology |
1 |
|
receptors, ccr5 - metabolism |
1 |
|
receptors, cell surface - metabolism |
1 |
|
receptors, chemokine - genetics - immunology |
1 |
|
receptors, chemokine - genetics - physiology |
1 |
|
receptors, cxcr4 - genetics - physiology |
1 |
|
receptors, cytokine - genetics - metabolism |
1 |
|
receptors, cytokine - genetics - physiology |
1 |
|
receptors, hiv - genetics - metabolism |
1 |
|
receptors, hiv - metabolism |
1 |
|
receptors, hiv - physiology |
1 |
|
receptors, interferon - deficiency |
1 |
|
receptors, virus - genetics - metabolism |
1 |
|
receptors, virus - genetics - physiology |
1 |
|
receptors, virus - metabolism |
1 |
|
recombinant proteins - biosynthesis |
1 |
|
rectal mucosal infection |
1 |
|
regulation system |
1 |
|
retroviridae proteins - genetics - immunology - metabolism |
1 |
|
reverse transcriptase inhibitors - chemistry - pharmacology - therapeutic use |
1 |
|
reverse transcriptase polymerase chain reaction |
1 |
|
rhesus macaques |
1 |
|
rhesus monkey viral antibody simian retrovirus |
1 |
|
risk factors |
1 |
|
rna, viral - blood |
1 |
|
rt gene mutation |
1 |
|
rt-shiv |
1 |
|
rural population |
1 |
|
sars virus - genetics |
1 |
|
sars virus - genetics - immunology - pathogenicity - physiology |
1 |
|
sentinel surveillance |
1 |
|
sequence alignment |
1 |
|
sequence analysis, dna |
1 |
|
sequence deletion |
1 |
|
sequence homology |
1 |
|
sequence homology, amino acid |
1 |
|
severe acute respiratory syndrome - immunology - prevention & control - virology |
1 |
|
sex ratio |
1 |
|
sexually transmitted diseases, viral - immunology - transmission - virology |
1 |
|
shivchn19p4 |
1 |
|
simian acquired immunodeficiency syndrome - etiology - immunology - virology |
1 |
|
simian acquired immunodeficiency syndrome - genetics - immunology |
1 |
|
simian acquired immunodeficiency syndrome - immunology - physiopathology - transmission - virology |
1 |
|
simian acquired immunodeficiency syndrome - immunology - virology |
1 |
|
simian immunodeficiency virus |
1 |
|
simian immunodeficiency virus - classification |
1 |
|
simian immunodeficiency virus - classification - genetics - immunology |
1 |
|
simian immunodeficiency virus - classification - metabolism - pathogenicity |
1 |
|
simian immunodeficiency virus - genetics - immunology - isolation & purification |
1 |
|
simian immunodeficiency virus - genetics - isolation and purification |
1 |
|
simian immunodeficiency virus - genetics - metabolism |
1 |
|
simian immunodeficiency virus - genetics - metabolism - pathogenicity |
1 |
|
simian immunodeficiency virus - genetics - pathogenicity - physiology |
1 |
|
simian immunodeficiency virus - immunology |
1 |
|
simian immunodeficiency virus - isolation & purification - pathogenicity - physiology |
1 |
|
simian immunodeficiency virus - isolation & purification - physiology |
1 |
|
simian immunodeficiency virus - physiology |
1 |
|
simian/human immunodeficiency virus |
1 |
|
sivmac239 |
1 |
|
sivrcm |
1 |
|
smallpox vaccine |
1 |
|
solubility |
1 |
|
southern hybridization |
1 |
|
southern雜交 |
1 |
|
species specificity |
1 |
|
spleen - cytology - immunology - metabolism |
1 |
|
srv-1 |
1 |
|
substance abuse, intravenous - epidemiology |
1 |
|
substance use disorders |
1 |
|
subtype b′ |
1 |
|
subtype c |
1 |
|
t-lymphocytes |
1 |
|
tak-779 |
1 |
|
therapeutic dna vaccine |
1 |
|
tissue tropism |
1 |
|
transfection |
1 |
|
transgenic plasmodium berghei |
1 |
|
transmitted drug resistance |
1 |
|
vaccination route |
1 |
|
vaccines, attenuated - administration and dosage - adverse effects |
1 |
|
vaccines, dna - administration & dosage - genetics |
1 |
|
vaccines, dna - administration & dosage - genetics - immunology |
1 |
|
vaccines, dna - immunology |
1 |
|
vaccines, dna - immunology - pharmacology |
1 |
|
vaccines, subunit - immunology |
1 |
|
vaccinia - physiopathology - virology |
1 |
|
vaccinia vector |
1 |
|
vaccinia virus - classification - growth & development - pathogenicity - ultrastructure |
1 |
|
vaccinia virus - genetics - physiology |
1 |
|
vagina - virology |
1 |
|
vaginal transmission |
1 |
|
viral envelope proteins - chemistry - genetics - immunology - physiology |
1 |
|
viral envelope proteins - genetics |
1 |
|
viral envelope proteins - genetics - immunology - metabolism |
1 |
|
viral envelope proteins - genetics - metabolism |
1 |
|
viral envelope proteins - metabolism |
1 |
|
viral genome engineering |
1 |
|
viral load |
1 |
|
viral matrix proteins - immunology |
1 |
|
viral vaccines - administration & dosage - genetics |
1 |
|
viral vaccines - administration & dosage - genetics - immunology |
1 |
|
viremia |
1 |
|
viremia - blood |
1 |
|
virulence |
1 |
|
virulence - genetics - immunology - physiology |
1 |
|
virus assembly |
1 |
|
virus attachment |
1 |
|
virus cultivation |
1 |
|
virus replication - drug effects - physiology |
1 |
|
virus replication - immunology |
1 |
|
viruses |
1 |
|
weight loss |
1 |
|
yeast surface display |
1 |
|
yunnan |
1 |
|
zidovudine - pharmacology |
1 |
|
α-galactosylceramide |
1 |
|
δ24 defect |
1 |
|
δ42pd1 |
1 |
|
光敏生物素探針 |
1 |
|
分子克隆 |
1 |
|
恒河猴 |
1 |
|
病毒抗體 |
1 |
|
直腸黏膜感染 |
1 |
|
細胞免疫應答 |
1 |
